St. Jude Medical's Infinity DBS system gains FDA approval for Parkinson's disease, essential tremor

St. Jude Medical announced Thursday that the FDA approved the Infinity deep brain stimulation (DBS) system for the treatment of Parkinson’s disease and essential tremor, along with the company's DBS directional lead, which is "the first directional lead approved in the US." St. Jude Medical said the system "provides a discreet, personalised experience for patients…while delivering targeted relief of only the necessary areas."

According to Allen Burton, vice president of medical affairs, the Infinity DBS system was "designed to streamline therapy programming" and "to provide patients with the best possible experience to manage their symptoms in a discreet manner." Specifically, the system, which features the first wireless iOS software platform available to DBS patients, uses a clinician programmer with an iPad mini mobile digital device and an iPod touch mobile digital device patient controller with Bluetooth connectivity.

Last year, St. Jude Medical announced that the system and directional DBS lead gained CE mark approval. 

Did you like this article?